Targeting the miR-19b/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damage. Kashani E, Sadowski MC, Phour J, Hashemi Gheinani A, et al. Br J Cancer 2026 May 27. doi: 10.1038/s41416-026-03474.

Read + Share

Amedeo Smart

Independent Medical Education

Kashani E, Sadowski MC, Phour J, Hashemi Gheinani A, et al. Targeting the miR-19b/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damage. Br J Cancer 2026 May 27. doi: 10.1038/s41416-026-03474.
PMID: 42203893